Original language | English (US) |
---|---|
Pages (from-to) | 1117-1118 |
Number of pages | 2 |
Journal | JAMA cardiology |
Volume | 6 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2021 |
Funding
grants from Janssen and personal fees from Janssen, AstraZeneca, Sanofi, and Pfizer outside the submitted work. Dr McNally reports personal fees from Amgen, AstraZeneca, Avidity Biosciences, 4D Molecular Therapeutics, Cytokinetics, Janssen, PepGen, Pfizer, Invitae, and Tenaya Therapeutics outside the submitted work and is the founder of Ikaika Therapeutics. No other disclosures were reported.
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine